Rchr
J-GLOBAL ID:201801002484535664
Update date: Aug. 14, 2024
Hamaguchi Shigeto
ハマグチ シゲト | Hamaguchi Shigeto
Affiliation and department:
Job title:
Associate Professor
Research field (1):
Infectious disease
Research theme for competitive and other funds (7):
- 2024 - 2027 感染症に強い介護環境を提供する感染管理認定看護師によるプラットフォームの構築
- 2023 - 2027 感染症に強い介護環境を提供する感染管理認定看護師によるプラットフォームの構築
- 2021 - 2024 高齢者ケア事業所職員の感染対策リテラシー向上を目指した地域横断的プログラムの構築
- 2021 - 2024 ナノポア技術と機械学習を用いた新たな微生物迅速診断検査系の確立
- 2019 - 2022 Elucidation of the mode of progression of Streptococcus pneumoniae from intranasal carriage to pneumonia.
- 2019 - 2022 Investigation on carbapenemase-producing Enterobacteriaceae in Myanmar from a molecular epidemiological and geopolitical point of view
- 2013 - 2017 New strategy for critically ill patients by control of NETs
Show all
Papers (108):
-
Tania Tabassum Nisa, Yo Sugawara, Shigeto Hamaguchi, Dan Takeuchi, Ryuichiro Abe, Eisuke Kuroda, Masatomo Morita, Hui Zuo, Akiko Ueda, Isao Nishi, et al. Genomic characterization of carbapenemase-producing Enterobacterales from Dhaka food markets unveils the spread of high-risk antimicrobial-resistant clones and plasmids co-carrying blaNDM and mcr-1.1. JAC-Antimicrobial Resistance. 2024. 6. 4
-
Daisuke Onozuka, Satoko Takatera, Hiroo Matsuo, Hisao Yoshida, Shigeto Hamaguchi, Shungo Yamamoto, Ryuichi Minoda Sada, Koichiro Suzuki, Keiji Konishi, Satoshi Kutsuna. Oral mouthwashes for asymptomatic to mildly symptomatic adults with COVID-19 and salivary viral load: a randomized, placebo-controlled, open-label clinical trial. BMC oral health. 2024. 24. 1. 491-491
-
Ryuichi Minoda Sada, Hiroo Matsuo, Daisuke Motooka, Satoshi Kutsuna, Shigeto Hamaguchi, Go Yamamoto, Akiko Ueda. Clostridium butyricum Bacteremia Associated with Probiotic Use, Japan. Emerging Infectious Diseases. 2024. 30. 4. 665-671
-
Ryuichi Minoda Sada, Hiroo Matsuo, Daisuke Motooka, Satoshi Kutsuna, Shigeto Hamaguchi, Go Yamamoto, Akiko Ueda. Clostridium butyricum Bacteremia Associated with Probiotic Use, Japan. Emerging infectious diseases. 2024. 30. 4. 665-671
-
Ayumi Morimura, Masateru Taniguchi, Hiroyasu Takei, Osamu Sakamoto, Norihiko Naono, Yukihiro Akeda, Daisuke Onozuka, Jumpei Yoshimura, Kazunori Tomono, Satoshi Kutsuna, et al. Using novel micropore technology combined with artificial intelligence to differentiate Staphylococcus aureus and Staphylococcus epidermidis. Scientific Reports. 2024. 14. 1
more...
MISC (24):
-
野口貴弘, 橘敬祐, 井上豪, 阪井丘芳, 辻川和丈, 藤尾慈, 山岸義晃, 濱口重人, 忽那賢志, 近藤昌夫. Safety evaluation of innovative medical material Matching Transformation System (MA-T) in mice: histological analysis of organs. 日本薬学会年会要旨集(Web). 2023. 143rd
-
前田大槻, 鍵田正智, 鍵田正智, 吉岡範, 吉岡範, 出口松夫, 塚本寛子, 塚本寛子, 高尾美有紀, 高尾美有紀, et al. 新型コロナウイルス抗体定量試薬「Access SARS-CoV-2 IgG II」の性能評価. 医療検査と自動化(Web). 2021. 46. 4
-
高尾美有紀, 高尾美有紀, 鍵田正智, 鍵田正智, 吉岡範, 吉岡範, 出口松夫, 塚本寛子, 塚本寛子, 前田大槻, et al. 新型コロナウイルス抗体定量試薬「ADVIA Centaur SARS-CoV-2 IgG(sCOVG)」の性能評価. 医療検査と自動化(Web). 2021. 46. 4
-
吉岡範, 吉岡範, 出口松夫, 鍵田正智, 鍵田正智, 塚本寛子, 塚本寛子, 高尾美有紀, 高尾美有紀, 前田大槻, et al. 新型コロナウイルス感染症検査診断法の比較. 医療検査と自動化(Web). 2021. 46. 4
-
鍵田正智, 鍵田正智, 吉岡範, 吉岡範, 出口松夫, 塚本寛子, 塚本寛子, 高尾美有紀, 高尾美有紀, 前田大槻, et al. 富士レビオ社新型コロナウイルス抗体定量試薬「SARS-CoV-2 S-IgG(IB)」の性能評価. 医療検査と自動化(Web). 2021. 46. 4
more...
Return to Previous Page